|Icone Imprimer

Axis 1 : « From development and validation of pronostic and predictive biomarkers to therapeutic innovation »

Steering committee: T. Frebourg, Y. de Launoit, P. Michel, G. Zalcman.

The majority of the clinical and basic research teams in the four-region group are dedicated to this axis and to two key projects in particular, which focus respectively on colorectal cancer and thoracic cancer and fit in perfectly with CNO's policy of promoting and developing translational research.

2011 - 2014 

Hence, the axis 1 team has decided to implement 2 flagship research projects over the period: 

  • Flagship programme : “The genetic determinism of colorectal cancer and breast cancer”
  • Flagship programme : “Mechanisms of resistance to antiEGFR drugs”